MARKET

MLTX

MLTX

MoonLake Immunotherapeutics
NASDAQ
19.19
+0.50
+2.68%
After Hours: 18.90 -0.29 -1.51% 19:24 06/15 EDT
OPEN
19.00
PREV CLOSE
18.69
HIGH
19.21
LOW
18.65
VOLUME
576.55K
TURNOVER
--
52 WEEK HIGH
62.75
52 WEEK LOW
5.95
MARKET CAP
1.41B
P/E (TTM)
-4.9594
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Celldex (CLDX) and MoonLake Immunotherapeutics (MLTX)
TipRanks · 10h ago
Weekly Report: what happened at MLTX last week (0608-0612)?
Weekly Report · 14h ago
MoonLake shareholders back director, auditor and compensation plans
TipRanks · 6d ago
Moonlake Immunotherapeutics shareholders approve amended 2022 equity incentive plan, adding 5 million shares
PUBT · 6d ago
MoonLake Immunotherap Price Target Maintained With a $30.00/Share by BTIG
Dow Jones · 6d ago
BTIG Reiterates Buy on MoonLake, Maintains $30 Price Target
Benzinga · 6d ago
Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immunotherapeutics (MLTX) and MBX Biosciences, Inc. (MBX)
TipRanks · 06/08 16:40
MoonLake’s Phase 3 Sonelokimab Trial Reaches Completion in Hidradenitis Suppurativa
TipRanks · 06/08 16:30
More
About MLTX
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.

Webull offers MoonLake Immunotherapeutics stock information, including NASDAQ: MLTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MLTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MLTX stock methods without spending real money on the virtual paper trading platform.